News

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...
Vaccination was cost saving for participants aged 65 years and older. In phase 2 analyses, an additional dose was ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...